Search

A new drug is showing potent results in hard-to-treat blood cancers and was able to trigger a complete response – meaning the cancer became undetectable – for more than a third of patients. All patients in the Phase I /... Read more

One role of the ICCon partnership is to establish a national database of individuals found to have gene faults or mutations causing an increased risk of cancer. Databases such as this enable researchers to investigate the causes... Read more

In line with our Patient Charter we will give you information through open and honest discussion, to help you make decisions about your treatment and care.   Respect  You have the right to:  Be treated with... Read more

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with certain subtypes of acute myeloid leukaemia (AML). The treatment works by using a combination of two agents,... Read more

A Peter Mac-led study has shown whole genome and transcriptome sequencing (WGTS) was able to solve diagnostic mysteries for more than a third of patients with rare inherited blood diseases. All patients in the study met criteria... Read more

Peter Mac’s Associate Professor Belinda Campbell will use a new fellowship to find practical solutions to improve equity of care for patients with cutaneous T-cell lymphomas – no matter... Read more